| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8241 |
| Human Intestinal Absorption | HIA+ | 0.9274 |
| Caco-2 Permeability | Caco2+ | 0.5154 |
| P-glycoprotein Substrate | Substrate | 0.5713 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8478 |
| Non-inhibitor | 0.9445 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9041 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5435 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8451 |
| CYP450 2D6 Substrate | Non-substrate | 0.6953 |
| CYP450 3A4 Substrate | Non-substrate | 0.6210 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8433 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8261 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8861 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8753 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8822 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5534 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9807 |
| Non-inhibitor | 0.8349 |
| AMES Toxicity | Non AMES toxic | 0.8725 |
| Carcinogens | Non-carcinogens | 0.5823 |
| Fish Toxicity | High FHMT | 0.8689 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9973 |
| Honey Bee Toxicity | Low HBT | 0.7587 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.6017 |
| Carcinogenicity (Three-class) | Non-required | 0.5282 |